El Festival Argentino USA invita al Día del Jugador Apasionado

Mar

Actualidad, EntretenimientoEl Festival Argentino USA invita al Día del Jugador Apasionado

El Festival Argentino USA invita al Día del Jugador Apasionado

Arlington, Virginia - El Festival Argentino USA, en colaboraciÃ³n con la organizaciÃ³n Kicking for a Dream, invita a la comunidad al DÃa del Jugador Apasionado en celebraciÃ³n de los 201 aÃ±os de relaciones entre EE.UU. y Argentina y la Copa Mundial de Clubes FIFA.Â La cita serÃ¡ el sÃ¡bado 31…

El Festival Argentino USA invita al Día del Jugador Apasionado

El Festival Argentino USA invita al Día del Jugador Apasionado

Comisionados de Seguridad despedidos ilegalmente

ZYXI Deadline: Rosen Law Firm Urges Zynex, Inc. (NASDAQ: ZYXI) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Be Biopharma Announces New Preclinical Data for BE-102, a B Cell Medicine for the Potential Treatment of Hypophosphatasia

AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B

Rocket Lab Successfully Launches Third Mission for iQPS in Multi-Launch Contract, Sets Schedule For the Next iQPS Mission

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease

Comisionados de Seguridad despedidos ilegalmente

ZYXI Deadline: Rosen Law Firm Urges Zynex, Inc. (NASDAQ: ZYXI) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Be Biopharma Announces New Preclinical Data for BE-102, a B Cell Medicine for the Potential Treatment of Hypophosphatasia

AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B

Rocket Lab Successfully Launches Third Mission for iQPS in Multi-Launch Contract, Sets Schedule For the Next iQPS Mission

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease

Comisionados de Seguridad despedidos ilegalmente

ZYXI Deadline: Rosen Law Firm Urges Zynex, Inc. (NASDAQ: ZYXI) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Be Biopharma Announces New Preclinical Data for BE-102, a B Cell Medicine for the Potential Treatment of Hypophosphatasia

AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B

Rocket Lab Successfully Launches Third Mission for iQPS in Multi-Launch Contract, Sets Schedule For the Next iQPS Mission

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease